![Mark L. Peterson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark L. Peterson active positions
Companies | Position | Start | End |
---|---|---|---|
Cyclenium Pharma, Inc.
![]() Cyclenium Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cyclenium Pharma, Inc. is a privately held pharmaceutical research and development company based in Montréal, Canada. The Canadian company is focused on creating value through the progression of internal programs in oncology, infectious diseases, and inflammation/pain. Cyclenium is also providing its extensive experience and exploring its CMRT-based Quest™ screening library in risk-sharing partnerships with leading academic and research-driven non-profit organizations, as well as collaborations with innovative pharmaceutical and biotechnology companies worldwide seeking to modulate unique and difficult disease targets in diverse therapeutic areas. The company was founded by Mark L. Peterson, and the CEO is Helmut Thomas. | Chief Operating Officer | - | - |
Founder | - | - | |
Corporate Secretary | - | - |
Career history of Mark L. Peterson
Statistics
International
Canada | 2 |
Operational
Chief Operating Officer | 1 |
Founder | 1 |
Corporate Secretary | 1 |
Sectoral
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Cyclenium Pharma, Inc.
![]() Cyclenium Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cyclenium Pharma, Inc. is a privately held pharmaceutical research and development company based in Montréal, Canada. The Canadian company is focused on creating value through the progression of internal programs in oncology, infectious diseases, and inflammation/pain. Cyclenium is also providing its extensive experience and exploring its CMRT-based Quest™ screening library in risk-sharing partnerships with leading academic and research-driven non-profit organizations, as well as collaborations with innovative pharmaceutical and biotechnology companies worldwide seeking to modulate unique and difficult disease targets in diverse therapeutic areas. The company was founded by Mark L. Peterson, and the CEO is Helmut Thomas. | Health Technology |
- Stock Market
- Insiders
- Mark L. Peterson
- Experience